SPAR Group, Inc.
SGRP News Today: Stay Updated with the Latest SPAR Group, Inc. News in Real Time
Find SGRP news now at Meyka AI. Stay informed with the latest SPAR Group, Inc. stocks updates, including price news, market analysis, and expert insights.
100,000-share spike in 8161.HK MediNet Group Limited (HKSE) on 24 Feb 2026: watch momentum
Intraday volume spike in 8161.HK stock on 24 Feb 2026 to 100,000 shares; analyze catalyst, valuation and Meyka AI forecast
Australian Shares Flat Amid Monadelphous Group’s Fiscal H1 Revenue Growth
We saw Australian shares close mostly flat today, even as one of the country’s major industrial groups posted very strong revenue growth. The S&P/ASX 200 barely budged, ending the session almost unchanged, reflecting caution among traders. The lack of major movement in the broader market highlights mixed sentiment. On the one hand, solid company earnings…
28,500 shares trade ABZT Ablaze Technologies (PNK) 24 Feb 2026: volume shows interest
ABZT stock jumps on high volume on 24 Feb 2026; volume, liquidity and a Meyka AI forecast reviewed
Maintained Buy by Deutsche Bank on Bank of Ireland Group plc (BKRIY) Feb 23 2026
BKRIY analyst rating: Deutsche Bank maintained Buy and raised price target to EUR 19.40 on Feb 23, 2026
Vanuatu on February 24: Whooping Cough Declines, Travel Risk Eases
Vanuatu whooping cough under control: 795 cases, seven deaths since June 2025, no new cases. What this means for UK travellers, risk, and the Pacific travel outlook.
ASWN.SW down 5.26% pre-market on SIX 24 Feb 2026: watch support
Pre-market update: ASWN.SW stock at CHF0.63. Meyka grade, forecasts and near-term risks for investors
February 24: Jalisco CJNG Violence Disrupts Flights, Hits Tourism Outlook
February 24: CJNG violence in Jalisco after El Mencho death disrupts flights and clouds Mexico tourism. What Swiss travelers and investors should watch now.
NTPL The Netplex Group, Inc. (PNK) trades at $0.000001 24 Feb 2026: volume alert
NTPL stock trades at $0.000001 on 24 Feb 2026 with a volume spike; short-term liquidity and large upside in Meyka AI forecast
Goldman Sachs, H.C. Wainwright Maintain Buy on ImmunityBio, Inc. (IBRX) Feb 2026
IBRX analyst rating: Goldman Sachs and H.C. Wainwright maintain Buy on ImmunityBio on Feb 23, 2026; H.C. Wainwright raises PT to $15